Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins

scientific article published on 21 November 2019

Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2217/CNS-2019-0001
P932PMC publication ID6880302
P698PubMed publication ID31747788

P2093author name stringSantosh Kesari
Achal S Achrol
Charlie Zhang
Emily Cox
Joshua Loya
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivativesQ6937225
P433issue3
P921main subjectbrain tumorQ233309
gliomaQ1365309
antineoplasticQ2853144
P304page(s)CNS38
P577publication date2019-11-01
2019-11-21
P1433published inCNS oncologyQ26842350
P1476titleBiological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
P478volume8

Reverse relations

Q90160575miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7cites workP2860

Search more.